CLINICAL ROLE -
The Budgetary Impact of Promising Prostate Cancer Drugs
With recent therapeutic advances, the treatment landscape for metastatic castration-resistant prostate cancer is changing rapidly.
Read More
Magnetoelectric Nanoparticles Offer Glimpse at Potential Future of Oncology
Nanoparticles acting as cancer drug delivery vehicles show promise in eliminating tumors.
Opinions Vary on Biosimilar Naming Conventions
Controversy swirls around the naming protocol for biosimilars among drug manufacturers and the FDA.
Prescription Drug Pricing Trends Continue to Raise Concerns
Mergers and acquisitions among pharmacy benefit managers may help limit medication cost hikes.
Emerging Trends in Payor Management and Health Plan Claims
Transition of provider-administered drugs from the physician office to the hospital remains a key cost driver of pharmacy spend.
Key Considerations in Bringing a Biosimilar Drug to Market
There are several ongoing global phase 3 clinical trials for biosimilar adalimumab, which treats conditions such as rheumatoid arthritis, psoriatic arthritis, and Crohn's Disease.
Polypharmacy Drug Regimen Modifications Lead to Cost Savings
Approximately 40% of the elderly and nearly 11% of the US population take 5 or more prescription drugs.
Do Automatic Refill Programs Improve Specialty Drug Adherence?
Specialty pharmacy automatic refill programs weigh improved adherence versus medication oversupply.
Management Tools for Controlling Specialty Drug Costs
Specialty benefit design and management tools can ensure optimal patient care.
How do Medicaid Prescription Caps Impact Adherence?
States have instituted multiple policies to control prescription drug costs, including limits on the number of reimbursable prescriptions.
The Impact of Automatic Refill Programs on Medication Adherence
Concerns persist that automatic prescription refill programs increase medication oversupply.
What Drives Health Care Cost Increases in High Resource Patients?
Efforts to limit access to medications could have a negative impact on overall expenditures.
The Impact of e-Prescribing Systems on PBM Formulary Management
Electronic prescribing systems can influence prescriber behavior and may result in lower prescription medication costs.
The Role of PBMs in Providing Access to Effective Care for Idiopathic Pulmonary Fibrosis
The annual cost to the Medicare system for IPF is estimated to be $1 billion annually.
PBM Tools Play Key Role in Managing Specialty Drug Costs
Specialty benefit design and management tools employed by pharmacy benefit managers can help control specialty drug spending and ensure optimal patient care.
Precision Medicine and Immune-Oncology Transform Cancer Treatment
Cancer treatment advances are now moving to the clinic with great promise, just as precision therapy and immunotherapy are transforming cancer therapy itself.
Legislators Address Concerns About Rising Drug Costs
Prohibitive cost to Medicaid for hepatitis C medications and high prices of generic and off-patent drugs evaluated.
Coffee Consumption Found to Reduce Risk of Cirrhosis
Coffee appears to confer a number of protective effects against liver disease.